Join us for an important webinar in collaboration with our national partner, Slater and Gordon, as we explore mesothelioma - a rare and aggressive cancer linked to asbestos exposure.
Although asbestos use was banned decades ago, the legacy of exposure continues to emerge in our hospitals and cancer care settings. November is Asbestos Awareness Month - a timely reminder that asbestos-related diseases such as mesothelioma, lung cancer, and asbestosis remain very real health concerns.
This clinical update features key medical articles from global journals with commentary from Bronwyn Jennings, the Gynae Oncology Clinical Nurse Consultant at Mater Hospital Brisbane, Australia and Chair of CNSA's Gynaecological Oncology Specialist Practice Network.
We are thrilled to congratulate Melanie Rabbets as the recipient of the 2025 Slater and Gordon World Lung Cancer Conference Scholarship.
Thanks to the generous support of our long-standing partners at Slater and Gordon, Melanie will travel to Barcelona, Spain, to attend the 2025 World Conference on Lung Cancer (WLCC) in September.
This session explores the latest developments in targeted therapies for non-small cell lung cancer (NSCLC), helping cancer nurses strengthen their knowledge of EGFR mutations, emerging treatments, and nursing management in practice.
Our friends at Slater and Gordon have received fantastic feedback and interest following their breakfast sessions at the CNSA and ICCN Congress. Want to know more?
We are pleased to congratulate our colleagues at the Clinical Oncology Society of Australia (COSA) on the launch of a landmark research report—E-Cigarettes and Cancer—which presents a qualitative risk assessment of the evidence linking e-cigarette use to cancer.
This event will explore the latest advancements in screening technologies, innovative treatment approaches, and strategies to improve outcomes for lung cancer patients.
